J M Calvo Romero

Summary

Country: Spain

Publications

  1. doi request reprint [New oral anticoagulants in the treatment of venous thromboembolic disease]
    J M Calvo Romero
    Servicio de Medicina Interna, Hospital Ciudad de Coria, Coria, Caceres, Espana
    Semergen 39:146-9. 2013
  2. doi request reprint [Recurrence risk in venous thromboembolic disease after anticoagulation discontinuation]
    José María Calvo Romero
    Servicio de Medicina Interna, Hospital Ciudad de Coria, Coria, Caceres, Spain
    Med Clin (Barc) 140:310-3. 2013
  3. doi request reprint Vitamin B(12) in type 2 diabetic patients treated with metformin
    José María Calvo Romero
    Servicio de Medicina Interna, Hospital Ciudad de Coria, Coria, Caceres, Espana
    Endocrinol Nutr 59:487-90. 2012
  4. doi request reprint [Should dabigatran or vitamin K antagonists be used in prevention of stroke in patients with atrial fibrillation?]
    J M Calvo Romero
    Servicio de Medicina Interna, Hospital Ciudad de Coria, Coria, Caceres, Espana
    Rev Clin Esp 211:142-6. 2011
  5. ncbi request reprint [Cancer in patients with venous thromboembolic disease]
    J M Calvo Romero
    Servicio de Medicina Interna Hospital Ciudad de Coria, Coria, Caceres, Spain
    An Med Interna 24:571-3. 2007

Detail Information

Publications5

  1. doi request reprint [New oral anticoagulants in the treatment of venous thromboembolic disease]
    J M Calvo Romero
    Servicio de Medicina Interna, Hospital Ciudad de Coria, Coria, Caceres, Espana
    Semergen 39:146-9. 2013
    ..These new oral anticoagulants have demonstrated to be effective and safe in clinical trials on the treatment of venous thromboembolic disease (deep vein thrombosis and pulmonary thromboembolism)...
  2. doi request reprint [Recurrence risk in venous thromboembolic disease after anticoagulation discontinuation]
    José María Calvo Romero
    Servicio de Medicina Interna, Hospital Ciudad de Coria, Coria, Caceres, Spain
    Med Clin (Barc) 140:310-3. 2013
    ..Clinical risk factors, elevated D-dimer after anticoagulation withdrawal and the presence of residual deep vein thrombosis should be considered. In this article the risk factors and the reported risk models are reviewed...
  3. doi request reprint Vitamin B(12) in type 2 diabetic patients treated with metformin
    José María Calvo Romero
    Servicio de Medicina Interna, Hospital Ciudad de Coria, Coria, Caceres, Espana
    Endocrinol Nutr 59:487-90. 2012
    ..To test vitamin B12 plasma levels in type 2 diabetic patients treated with metformin in our area...
  4. doi request reprint [Should dabigatran or vitamin K antagonists be used in prevention of stroke in patients with atrial fibrillation?]
    J M Calvo Romero
    Servicio de Medicina Interna, Hospital Ciudad de Coria, Coria, Caceres, Espana
    Rev Clin Esp 211:142-6. 2011
    ..Its drawbacks are cost, lack of antidote and long-term data, frequency of dyspepsia and the twice daily dosage...
  5. ncbi request reprint [Cancer in patients with venous thromboembolic disease]
    J M Calvo Romero
    Servicio de Medicina Interna Hospital Ciudad de Coria, Coria, Caceres, Spain
    An Med Interna 24:571-3. 2007
    ..To study the characteristics of patients with venous thromboembolic disease (VTD) and cancer in our area...